Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,050
0.00 (0.00%)
At close: Sep 26, 2025
Market Cap233.92B
Revenue (ttm)276.35B
Net Income (ttm)10.83B
Shares Out17.92M
EPS (ttm)602.72
PE Ratio21.65
Forward PEn/a
Dividend150.00 (1.15%)
Ex-Dividend DateDec 27, 2024
Volumen/a
Average Volume10,164
Open13,050
Previous Close13,050
Day's Range13,050 - 13,050
52-Week Range9,540 - 15,490
Beta0.53
RSI54.62
Earnings DateNov 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 666
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.